Gujarat Themis Biosyn Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- Strong return on equity (ROE 17.4%)
Concerns
- Premium to sector peers (P/E 86.6x vs industry 50.2x)
- High premium to book value (P/B 16.3x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,758 | ₹4.2L Cr | 33.2 | 5.05 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹9,559 | ₹2.4L Cr | 79.8 | 15.15 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,557 | ₹1.7L Cr | 79.3 | 9.43 | 27.4 | 15.2 | 0.77 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,176 | ₹1.1L Cr | 23.1 | 4.37 | 21.2 | 21.1 | 0.38 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,137 | ₹1.1L Cr | 52.8 | 12.35 | 21.2 | 17.4 | 0.88 |
| CIPLA Cipla Limited | ₹1,366 | ₹1.1L Cr | 30.2 | 3.21 | 11.6 | 15.5 | 0.01 |
| LAURUSLABS Laurus Labs Limited | ₹2,182 | ₹1.1L Cr | 97.4 | 22.22 | 18.3 | 17.8 | 0.46 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
GUJTHEM · as of Dec 2025
| Category | Aug 2026 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|
| Promoters | 70.87% | 70.87% | 70.87% | 70.87% | 70.87% | 70.87% |
| FII | 2.95% | 0.86% | 1.05% | 1.44% | 1.49% | 1.42% |
| DII | 1.17% | 0.04% | 0.82% | 1.18% | 1.17% | 1.17% |
| Public | 25.01% | 28.23% | 27.26% | 26.52% | 26.47% | 26.55% |
Latest News
All newsGujarat Themis Biosyn receives credit rating update
*Gujarat Themis Biosyn receives credit rating update.* The company's recent credit rating has been disclosed in a regulatory filing. No financial figures or rating specifics were provided in the headline. This is a routine corporate disclosure with limited immediate trading impact. 📊 *STOCKS:* $GUJTHIMIS | 🏢 *SECTOR:* Pharma | #LOWIMPACT #CreditRating
Gujarat Themis Biosyn shares see general updates
*Gujarat Themis Biosyn shares see general updates* per a recent NSE filing. No specific financial or operational details were disclosed. The update does not indicate any **₹500Cr+** transaction or material event. Traders should await further clarity on corporate developments. 📊 *STOCKS:* $THEMIS | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Update
Gujarat Themis Biosyn holds 45th AGM
*Gujarat Themis Biosyn holds 45th AGM*. The company conducted its 45th Annual General Meeting, with the Scrutinizer's Report countersigned by the Chairman. No major announcements or financial updates were disclosed. The event was a routine corporate exercise. 📊 *STOCKS:* GujaratThemis | 🏢 *SECTOR:* Pharma | #LOWIMPACT #AGM
Gujarat Themis Biosyn to hold shareholder meeting on Sep 30, 2026
*Gujarat Themis Biosyn to hold shareholder meeting on Sep 30, 2026.* The company has scheduled a meeting of its shareholders for **September 30, 2026**, as per a corporate filing. Purpose of the meeting is not specified yet. Details are expected to be disclosed closer to the date. 📊 *STOCKS:* GTBL | 🏢 *SECTOR:* Pharma | #LOWIMPACT #ShareholderMeeting
Gujarat Themis acquires Japanese firm via private credit
*Gujarat Themis acquires Japanese firm via private credit*. The company funded the acquisition using private credit, marking a strategic expansion into Japan. This move strengthens its global footprint in the pharmaceutical sector. The deal size and terms were not disclosed. 📊 *STOCKS:* $GUJTHAN | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #Acquisition
Gujarat Themis Biosyn issues corrigendum to AGM notice
*Gujarat Themis Biosyn issues corrigendum to AGM notice* — The company has released a corrigendum to the notice of its 45th Annual General Meeting, clarifying previously communicated details. The update was published as per regulatory requirements. No financial or operational changes are indicated. 📊 *STOCKS:* $GUJTHIMIS | 🏢 *SECTOR:* Pharma | #LOWIMPACT #AGM
Gujarat Themis Biosyn announces general corporate updates
*Gujarat Themis Biosyn announces general corporate updates.* The filing provides routine information without disclosing financial figures or major strategic shifts. Investors await further clarity on operational developments. 📊 *STOCKS:* $THEMIS | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Corporate
Gujarat Themis Biosyn announces 45th AGM via newspaper notice
*Gujarat Themis Biosyn announces 45th AGM via newspaper notice*. The company has published notice of its **45th Annual General Meeting** as per regulatory requirements. No financial updates or material changes were disclosed. Event is routine and procedural in nature. 📊 *STOCKS:* $GTL | 🏢 *SECTOR:* Pharma | #LOWIMPACT #AGM
Gujarat Themis Biosyn submits postal ballot scrutiny report.
*Gujarat Themis Biosyn submits postal ballot scrutiny report.* The company filed the scrutinizer's report related to a recent postal ballot with the NSE. This follows standard corporate procedure for shareholder decisions. No immediate financial impact is indicated. 📊 *STOCKS:* THEMIS | 🏢 *SECTOR:* Pharma | #LOWIMPACT #PostalBallot
Gujarat Themis Biosyn holds shareholder postal ballot meeting
*Gujarat Themis Biosyn holds shareholder postal ballot meeting.* The company conducted a postal ballot and submitted the scrutinizer’s report with voting results to the exchange. No details on the resolution were disclosed. This is a routine corporate compliance filing. 📊 *STOCKS:* THEMIS | 🏢 *SECTOR:* Pharma | #LOWIMPACT #ShareholdersMeeting
About Gujarat Themis Biosyn Limited
Incorporated in 1981, Gujarat Themis Biosyn Ltd manufactures and sells finished Active Pharmaceutical Ingredients products by fermentation process[1]
HealthcarePharmaceuticals & Biotechnology